GSA CAPITAL PARTNERS LLP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 141 filers reported holding NOVAVAX INC in Q1 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2018$198,000
-83.6%
107,712
-83.3%
0.02%
-65.7%
Q3 2018$1,210,000
+8.4%
643,400
-22.7%
0.07%
+21.8%
Q2 2018$1,116,000
+341.1%
832,500
+590.9%
0.06%
+323.1%
Q1 2018$253,000
-83.2%
120,500
-90.1%
0.01%
-85.9%
Q4 2017$1,507,000
+17.8%
1,215,153
+8.3%
0.09%
+5.7%
Q3 2017$1,279,000
-34.2%
1,122,353
-33.6%
0.09%
-31.5%
Q2 2017$1,944,000
+24.6%
1,690,153
+38.7%
0.13%
+51.2%
Q1 2017$1,560,000
+796.6%
1,218,806
+3520.9%
0.08%
+663.6%
Q1 2016$174,000
-52.5%
33,660
-22.7%
0.01%
-38.9%
Q4 2015$366,000
-86.6%
43,570
-88.7%
0.02%
-86.6%
Q3 2015$2,725,000
+66.3%
385,468
+162.0%
0.13%
+112.7%
Q2 2015$1,639,000
+12.3%
147,137
-16.6%
0.06%
+8.6%
Q1 2015$1,459,000
+879.2%
176,480
+392.4%
0.06%
+625.0%
Q3 2014$149,000
+161.4%
35,840
+191.3%
0.01%
+166.7%
Q2 2014$57,000
-73.7%
12,304
-74.3%
0.00%
-80.0%
Q1 2014$217,00047,9170.02%
Other shareholders
NOVAVAX INC shareholders Q1 2014
NameSharesValueWeighting ↓
BB BIOTECH AG 8,330,000$10,496,0000.39%
Alden Global Capital LLC 640,500$807,0000.28%
Quantitative Investment Management, LLC 3,784,100$4,767,0000.12%
Eventide Asset Management 1,449,700$1,827,0000.12%
Bellevue Group AG 325,000$410,0000.08%
Virtus ETF Advisers LLC 196,162$247,0000.07%
Rock Springs Capital Management LP 820,000$1,033,0000.07%
Quantbot Technologies LP 462,250$582,0000.06%
Traynor Capital Management, Inc. 43,361$55,0000.04%
Tekla Capital Management LLC 571,000$719,0000.03%
View complete list of NOVAVAX INC shareholders